EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unlocking Mangiferin: A Therapeutic Candidate Revolutionizing Liver Disease Therapy

Jihang Xie, Sijing Su, Jianfa Wu, Xing Yang, Qian Zhang, Xiaojiang Shen, Linlin Zhao, Ting Wang iD, Nana Feng, Jinsong Su, Yi Zhang

Nutrients · 29.10.2025 · 17 (21) · 3401

DOI: 10.3390/nu17213401 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 29.10.2025. Verfasst von Jihang Xie und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611…. Hauptthemen laut MEDLINE: Xanthones, Liver Diseases, Antioxidants. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhangyi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mangiferin (MF), a natural component widely found in fruits, vegetables, and herbs, has garnered increasing attention for its potent antioxidative properties and therapeutic potential. This bioactive xanthone compound plays a crucial role in mitigating oxidative stress, which is a key factor in the pathogenesis of various diseases, including liver diseases. As a powerful natural antioxidant, MF exhibits a wide range of hepatoprotective effects, making it a promising candidate for liver disease therapy. In this review, we systematically examine the source and chemical properties, synthetic pathways, pharmacokinetic characteristics, and bioavailability enhancement strategies of MF. Furthermore, we explore its mechanisms of action in treating liver diseases, with a focus on its antioxidative properties and their role in modulating liver disease progression. Given the growing burden of liver disease and the limitations of current therapies, this review aims to promote the clinical application of MF as a therapeutic candidate, paving the way for innovative therapeutic strategies for liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

XanthonesLiver DiseasesAntioxidantsHumansOxidative StressAnimalsBiological AvailabilityLiver

Stichwörter der Autor:innen

bioavailabilitybiosynthesis and chemical synthesishepatoprotectionmangiferinoxidative stresstherapeutic candidate

Substanzen

XanthonesmangiferinAntioxidants

Autor:innen und Institutionen

  • State Key Laboratory of Southwestern Chinese Medicine Resources, College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • School of Ethmic Medicine, Chengdu University of Taditional Chinese Medicine, Chengdu 611137, China.
  • Fujian Key Laboratory of Polymer Materials, Fujian Provincial Key Laboratory of Advanced Materials Oriented Chemical Engineering, College of Chemistry and Materials Science, Fujian Normal University, Fuzhou 350007, Chin…
  • Innovation Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

ORCID-Profile: Ting Wang

Förderung

  • Zhangyi

Zitieren

APA

Xie, J., Su, S., Wu, J., Yang, X., Zhang, Q., Shen, X., Zhao, L., Wang, T., Feng, N., Su, J., & Zhang, Y. (2025). Unlocking Mangiferin: A Therapeutic Candidate Revolutionizing Liver Disease Therapy. Nutrients, 17(21), 3401. https://doi.org/10.3390/nu17213401

Vancouver

Xie J, Su S, Wu J, Yang X, Zhang Q, Shen X, et al. Unlocking Mangiferin: A Therapeutic Candidate Revolutionizing Liver Disease Therapy. Nutrients. 2025;17(21):3401. doi:10.3390/nu17213401

BibTeX
@article{Xie2025,
  author = {Xie, Jihang and Su, Sijing and Wu, Jianfa and Yang, Xing and Zhang, Qian and Shen, Xiaojiang and Zhao, Linlin and Wang, Ting and Feng, Nana and Su, Jinsong and Zhang, Yi},
  title = {Unlocking Mangiferin: A Therapeutic Candidate Revolutionizing Liver Disease Therapy},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {21},
  pages = {3401},
  doi = {10.3390/nu17213401}
}
Kostenlos starten →